C12N 2501/606
C-myc
Official title: c-Myc
C12N2501/606 (C-myc) appears on 256 US grants and 535 published applications in this corpus.
Search patents in C12N- Granted patents
- 256
- Published applications
- 535
- Assignees
- 234
- Inventors
- 843
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 9 |
| 2010 | 0 | 19 |
| 2011 | 2 | 35 |
| 2012 | 6 | 35 |
| 2013 | 9 | 37 |
| 2014 | 14 | 33 |
| 2015 | 18 | 34 |
| 2016 | 28 | 36 |
| 2017 | 23 | 44 |
| 2018 | 29 | 39 |
| 2019 | 21 | 28 |
| 2020 | 20 | 31 |
| 2021 | 17 | 35 |
| 2022 | 12 | 30 |
| 2023 | 11 | 23 |
| 2024 | 23 | 25 |
| 2025 | 15 | 29 |
| 2026 | 8 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Immune cells derived from induced pluripotent stem cell14 Jul 2026US 12,680,075 B2Children's Medical Center Corporation
- And efficient method for reprogramming blood to induced pluripotent stem cells14 Jul 2026US 12,680,082 B2Cedars-Sinai Medical Center
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Methods and compositions for reprogramming cells14 Apr 2026US 12,600,968 B2The Regents of the University of Colorado, a body corporate
- Oct3/4 protein variants, and method for producing induced pluripotent stem cells1 Oct 2026US 2026/0297535 A1Riken
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- System and method for capillary blood stem cell reprogramming using upper-arm blood collection devices for patient-specific disease modeling10 Sep 2026US 2026/0265698 A1TimepointDx
- Generation of induced pluripotent stem cells with polycistronic sox2, klf4, and optionally c-myc6 Aug 2026US 2026/0226422 A1Beixcell (Beijing) Biotechnology Ltd.
- Storage liquid for mammalian cells23 Jul 2026US 2026/0209682 A1Megakaryon Corporation
Most cited
By later US patents
- Nuclear reprogramming factor151US 8,048,999 B2Kyoto University · 2011
- Compositions and methods for reprogramming eukaryotic cells103US 8,808,982 B2Cellscript, LLC · 2014
- Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox284US 8,129,187 B2Kyoto University · 2012
- Integration-free human induced pluripotent stem cells from blood73US 8,048,675 B1iPierian, Inc. · 2011
- TGF-beta receptor inhibitors to enhance direct reprogramming55US 8,298,825 B1The General Hospital Corporation · 2012